Search by Drug Name or NDC
NDC 50844-0258-08 Headache Relief 250; 250; 65 mg/1; mg/1; mg/1 Details
Headache Relief 250; 250; 65 mg/1; mg/1; mg/1
Headache Relief is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by L.N.K. International, Inc.. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
| NDC | 50844-0258 |
|---|---|
| Product ID | 50844-258_c28e0a93-83a2-4b44-9027-8634a9367765 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Headache Relief |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Acetaminophen, Aspirin, Caffeine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 250; 250; 65 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Labeler Name | L.N.K. International, Inc. |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M013 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50844-0258-08 (50844025808)
| NDC Package Code | 50844-258-08 |
|---|---|
| Billing NDC | 50844025808 |
| Package | 1 BOTTLE in 1 CARTON (50844-258-08) / 24 TABLET, FILM COATED in 1 BOTTLE |
| Marketing Start Date | 2019-07-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |